Sai Life Sciences Limited, among India's fastest growing Contract Research, Development and Manufacturing Organizations (CRDMO), is announcing the ground breaking of a CMC Process R&D Center at its integrated R&D campus in Hyderabad...
Bayosthiti AI, an innovator in AI-driven healthcare and molecular diagnostics, announced a strategic partnership with Narayana Health, one of the world's largest cardiac care networks, to develop AI models that predict cardiovascular disease in India
Health Canada has issued a Notice of Compliance (NOC) to Zydus Lifesciences Limited for their generic 1000 mg mesalamine suppositories
Eli Lilly and Company announced a final deal for Lilly to purchase Adverum Biotechnologies, Inc. (Adverum), including its lead product candidate, Ixo-vec. Adverum Biotechnologies, Inc. is a clinical-stage company that is leading the use of intravitre
Eli Lilly and Company revealed today that it is to acquire the clinical-stage biotechnology company Adverum Biotechnologies, Inc., which is the leader in the development of intravitreal gene therapy to restore vision in patients with advanced...
Novartis announced on Sunday that it will acquire U.S.-based Avidity Biosciences for about $12 billion in cash in one of its largest deals to strengthen its pipeline of treatments for rare muscle disorders. Under the terms of the deal, Avidity...
Syngene International Ltd., a global leader in contract research, development, and manufacturing (CRDMO) services, has unveiled plans to set up a cutting-edge GMP bioconjugation suite at its commercial biologics facility (Unit 3) in Bengaluru
 (1).jpg)
Ipsen agreed to a definitive share purchase agreement to acquire ImCheck Therapeutics, a French privately-held biotechnology company that develops next-generation immuno-oncology therapies. Through this acquisition, Ipsen is focusing on the
.jpg)
According to B Thirunavukkarasu, president of the Bangalore District Chemists and Druggists Association (BDCDA), India requires a national Pharma Quality Certification & Audit (PQCA) system under the Quality Council of India (QCI) to strengthen drug
.png)
Merck KGaA, a premier science and technology company, today revealed up to-date Phase 3 data from the global MANEUVER trial of pimicotinib, an investigational CSF-1R antagonist developed in collaboration with Abbisko Therapeutics for the treatment...
.jpg)
, CDSCO.jpg)